133 related articles for article (PubMed ID: 33791708)
1. Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses.
Ordonez AA; Bullen CK; Villabona-Rueda AF; Thompson EA; Turner ML; Davis SL; Komm O; Powell JD; D'Alessio FR; Yolken RH; Jain SK; Jones-Brando L
bioRxiv; 2021 Mar; ():. PubMed ID: 33791708
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice.
Ordonez AA; Bullen CK; Villabona-Rueda AF; Thompson EA; Turner ML; Merino VF; Yan Y; Kim J; Davis SL; Komm O; Powell JD; D'Alessio FR; Yolken RH; Jain SK; Jones-Brando L
Commun Biol; 2022 Mar; 5(1):242. PubMed ID: 35304580
[TBL] [Abstract][Full Text] [Related]
3. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
[TBL] [Abstract][Full Text] [Related]
4. Effective inhibition of HCoV-OC43 and SARS-CoV-2 by phytochemicals in vitro and in vivo.
Ojha D; Jessop F; Bosio CM; Peterson KE
Int J Antimicrob Agents; 2023 Sep; 62(3):106893. PubMed ID: 37339711
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.
Keshavarz Valian N; Pourakbari B; Asna Ashari K; Hosseinpour Sadeghi R; Mahmoudi S
J Med Virol; 2022 Apr; 94(4):1450-1456. PubMed ID: 34786736
[TBL] [Abstract][Full Text] [Related]
6. Repurposing old drugs as antiviral agents for coronaviruses.
Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
8. An overview on the seven pathogenic human coronaviruses.
Kesheh MM; Hosseini P; Soltani S; Zandi M
Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs derived from the foot-and-mouth disease virus genome trigger broad antiviral activity against coronaviruses.
Rodríguez-Pulido M; Calvo-Pinilla E; Polo M; Saiz JC; Fernández-González R; Pericuesta E; Gutiérrez-Adán A; Sobrino F; Martín-Acebes MA; Sáiz M
Front Immunol; 2023; 14():1166725. PubMed ID: 37063925
[TBL] [Abstract][Full Text] [Related]
10. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
11. Animal Models of COVID-19: Transgenic Mouse Model.
Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
[TBL] [Abstract][Full Text] [Related]
13. Do Sputnik V Vaccine-Induced Antibodies Protect Against Seasonal Coronaviruses? Case Study.
Koryukov M; Kechin A; Shamovskaya D; Timofeeva A; Filipenko M
Viral Immunol; 2022 Mar; 35(2):138-141. PubMed ID: 35143357
[TBL] [Abstract][Full Text] [Related]
14. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
15. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
[TBL] [Abstract][Full Text] [Related]
16. Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2.
Hsu HY; Yang CW; Lee YZ; Lin YL; Chang SY; Yang RB; Liang JJ; Chao TL; Liao CC; Kao HC; Wu SH; Chang JY; Sytwu HK; Chen CT; Lee SJ
Front Pharmacol; 2021; 12():706901. PubMed ID: 34483914
[TBL] [Abstract][Full Text] [Related]
17. Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2.
Yan H; Sun J; Wang K; Wang H; Wu S; Bao L; He W; Wang D; Zhu A; Zhang T; Gao R; Dong B; Li J; Yang L; Zhong M; Lv Q; Qin F; Zhuang Z; Huang X; Yang X; Li Y; Che Y; Jiang J
Acta Pharm Sin B; 2021 Sep; 11(9):2850-2858. PubMed ID: 33723501
[TBL] [Abstract][Full Text] [Related]
18. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
Fischer N; Dauby N; Bossuyt N; Reynders M; Gérard M; Lacor P; Daelemans S; Lissoir B; Holemans X; Magerman K; Jouck D; Bourgeois M; Delaere B; Quoilin S; Van Gucht S; Thomas I; Barbezange C; Subissi L
Lancet Microbe; 2021 Mar; 2(3):e105-e114. PubMed ID: 33937883
[TBL] [Abstract][Full Text] [Related]
20. A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.
Cai Y; Xu W; Tang J; Cao N; Lan Q; Lu L; Jiang S
Cell Biosci; 2021 Jul; 11(1):128. PubMed ID: 34238357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
